Health Care

The U.S. auto safety agency has opened an investigation into complaints that another 1 million Fiat Chrysler vehicles can roll away after the owners shift transmissions into park, a problem similar to the one being blamed in the death of Star Trek actor Anton Yelchin.

U.S. health officials have approved a new option for some women battling ovarian cancer: a drug that targets a genetic mutation seen in some highly aggressive tumors.

CarMax Inc. and two other used-car retailers have settled complaints from federal regulators that they touted their inspections in advertising but failed to disclose that some of the vehicles were under safety recalls and unrepaired.

U.S. Sen. Charles Schumer is increasing the heat on the federal government to consider recalling e-cigarette batteries and devices that explode and catch fire, injuring users.

The Latest on Sen. Charles Schumer saying the federal government needs to look at exploding e-cigarettes (all times local): 2 p.m.

More than 8 million Cuisinart food processors are being recalled because pieces of the metal blade can break off into processed food.

Chipotle, which is still hurting from food safety scares last year, is adding four new people to its board as the burrito chain tries to turn its business around.

Mitsubishi is recalling more than 50,000 Outlander Sport SUVs because the rear hatch lift gate can suddenly fall on people.

Drugmaker Mylan has started selling a generic version of its emergency allergy treatment EpiPen at half the price of the branded option, the cost of which drew national scorn and attracted Congressional inquiries.

Hundreds of thousands of Americans have struggled with contaminated tap water throughout the U.S. this year.

Hundreds of thousands of Americans have struggled with contaminated tap water throughout the U.S. this year.

Mylan said on Friday it would start selling a generic version of its life-saving EpiPen allergy treatment at a more than 50 percent discount.

The Supreme Court upheld it, but the health-care industry still remains uncertain about the impact of President Obama's landmark health-care reform.

A federal jury in Delaware on Thursday ordered Gilead Sciences Inc. to pay $2.5 billion in damages to Merck & Co. for infringing its patents in developing hepatitis C drugs.

Eli Lilly shares are up sharply after it laid out a better-than-expected 2017 forecast nearly a month after it had announced the failure of a key Alzheimer's treatment in testing.

Connecticut and 19 other states filed a lawsuit on Thursday against Mylan NV, Teva Pharmaceuticals and four other generic drug makers saying they entered into illegal conspiracies that raised prices on two common generic drugs, the New York state attorney general's office said in a statement.

Pilloried for their role in the epidemic of prescription painkiller abuse, drugmakers are aggressively pushing their remedy to the problem: a new generation of harder-to-manipulate opioids that have racked up billions in sales, even though there's little proof they reduce rates of overdoses or deaths.

Taxpayers will fork over nearly $10 billion more next year to cover double-digit premium hikes for subsidized health insurance under President Barack Obama's law, according to a study being released Thursday.

Federal prosecutors have charged two former pharmaceutical executives with fixing prices of generic drugs, part of an ongoing government investigation into anticompetitive tactics by companies that make lower-cost drugs intended to reduce medication costs.